Thirty-day readmission rates after PCI in a metropolitan center in Europe. Issue 3 (March 2015)

• Record Type: Journal Article
• Authors: Moretti, Claudio; D'Ascenzo, Fabrizio; Omedè, Pierluigi; Sciuto, Filippo; Presutti, Davide Giacomo; Di Cuia, Marco; Colaci, Chiara; Giusto, Federico; Ballocca, Flavia; Cerrato, Enrico; Colombo, Francesco; Gonella, Anna; Giordana, Francesca; Longo, Giada; Vilardi, Ilaria; Bertaina, Maurizio; Orlando, Anna; Andrini, Rita; Ferrando, Alberto; DiNicolantonio, James J.; Zoccai, Giuseppe Biondi; Sheiban, Imad; Gaita, Fiorenzo
• Is Part Of: Journal of cardiovascular medicine. Volume 16:Issue 3(2015:Mar.)
• Publication Date: 2015-03
• Subjects: Cardiology -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; Cardiology -- Periodicals; Cardiovascular Diseases -- Periodicals; 616.1005
• DOI: 10.2459/JCM.0000000000000136
• Languages: English
• ISSNs: 1558-2027

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Introduction</title> <p>Thirty-day readmission rates after percutaneous coronary intervention (PCI) have been related to adverse prognosis, and represent one of the most investigated indicators of quality of care. These data, however, derive from non-European centers evaluating all-cause readmissions, without stratification for diagnosis.</p> </sec> <sec> <title>Methods</title> <p>All consecutive patients undergoing PCI at our center from January 2009 to December 2011 were enrolled. Thirty-day readmissions related to postinfarction angina, myocardial infarction, unstable angina or heart failure were defined as acute coronary syndrome (ACS) or heart failure rehospitalizations. Major cardiac adverse event (MACE) was the primary outcome, and its single components (death, myocardial infarction and repeated revascularization) the secondary ones.</p> </sec> <sec> <title>Results</title> <p>A total of 1192 patients were included; among them, 53 (4.7%) were readmitted within 30 days, and 25 (2.1%) were classified as ACS/heart failure related. During hospitalization, patients with ACS/heart failure readmissions were more likely to suffer a periprocedural myocardial infarction (22 vs. 4%; <italic>P</italic> = 0.012), and to undergo PCI at 30 days (52 vs. 0.5%; <italic>P</italic> < 0.001). Logistic regression analysis indicated that periprocedural myocardial infarction represented the only independent predictor of an ACS/heart failure readmission [odds ratio (OR) 4.5; 1.1–16.8; <italic>P</italic> = 0.047]. After a median follow-up of 787 days (434–1027; first and third quartiles), patients with a 30-day ACS/heart failure readmission experienced higher rates of MACE, all-cause death and myocardial infarction (64 vs. 21%, <italic>P</italic> < 0.001; 28 vs. 6%, <italic>P</italic> = 0.017; and 20 vs. 2.7%, <italic>P</italic> < 0.001, respectively). Cox multivariate analysis indicated that ACS/heart failure 30-day readmissions were independently related to an increased risk of all-cause death (OR 3.3; 1.1–8.8; <italic>P</italic> = 0.02), differently from 30-day non-ACS/heart failure readmissions (OR 3.1; 0.7–12.9; <italic>P</italic> = 0.12).</p> </sec> <sec> <title>Conclusion</title> <p>Thirty-day readmissions after PCI in an Italian center are infrequent, and only those patients with ACS/heart failure show a detrimental impact on prognosis who have periprocedural myocardial infarction as the only independent predictor.</p> </sec> </abstract>